Camp4 Therapeutics Ratios (2023-2026) | CAMP

Ratios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -3,544.00%-2,191.87%-1,590.68%-1,344.62%-1,774.09%-3,718.97%-944.13%
EBIT Margin (Quarter) -3,525.14%-2,152.45%-1,526.81%-870.27%-1,717.11%-3,671.26%-1,010.12%
EBITDA Margin (Quarter) -3,525.14%-2,152.45%-1,526.81%-870.27%-1,717.11%-3,671.26%-1,010.12%
Operating Margin (Quarter) -3,525.14%-2,152.45%-1,526.81%-870.27%-1,717.11%-3,671.26%-1,010.12%
Net Margin (Quarter) -3,544.00%-2,191.87%-1,590.68%-1,344.62%-1,774.09%-3,718.97%-944.13%
FCF Margin (Quarter) -1,771.63%-1,665.03%-709.55%-1,405.16%1,795.11%-848.61%
Efficiency
Assets Average (Quarter) 49.84M70.54M57.02M68.83M102.10M111.63M
Invested Capital (Quarter) 0.16M0.10M0.09M0.07M
Asset Utilization Ratio (Quarter) 0.010.020.050.060.030.04
Leverage & Solvency
Interest Coverage Ratio (Quarter) -16.34-29.04-11.67-19.48-1.31-16.19-11.53-1.72-15.58-14.58-233.41
Times Interest Earned (Quarter) -16.34-29.04-11.67-19.48-1.31-16.19-11.53-1.72-15.58-14.58-233.41
Valuation
Enterprise Value (Quarter) -50.47M-38.38M-2.53M-64.04M-49.30M-39.05M-75.25M-110.86M-99.94M
Return Ratios
Return on Sales (Quarter) -0.35%-1.50%-0.22%-0.16%-0.13%-0.18%-0.37%-0.09%
Return on Capital Employed (Quarter) -131.93%-83.17%-108.03%-88.32%-60.70%-55.29%
Return on Assets (Quarter) -0.01%-0.01%-0.01%-0.01%-0.01%-0.01%